The BioProcessUK conference offers a valuable opportunity to build and strengthen key business relationships, hear the latest developments in bioprocessing, and gain insights from high-profile speakers.
Building on the success of previous years, the event will once again deliver a dynamic programme, including pre-conference drinks, a two-day conference, and a buzzing exhibition showcasing the latest innovations from across the sector. The programme also features industry awards, student poster sessions where attendees will have the opportunity to take part in interactive voting, structured one-to-one partnering, and a dedicated networking dinner at the end of conference day one.
Who attends?
The bioProcessUK audience will comprise of leaders and experts advancing the future of bioprocessing and manufacturing, including:
Pharma, biotech scientists and engineers developing processes across a wide range of therapies, including biologics, vaccines, cell and gene therapies, and next generation modalities such as RNA and ADCs.
Bioprocessing and manufacturing C-suite leaders shaping strategy, scaling production, and driving operational excellence in biotech and pharma companies.
Senior academics, early-career researchers and emerging talent contributing fresh perspectives and supporting the future workforce of the sector.
Therapy developers, from large pharma to emerging biotech, service providers such as CDMOs and CROs, and supply chain organisations.
Spanning early-career researchers through to C-suite decision-makers, bioProcessUK offers a unique opportunity to connect with a highly technical and senior audience shaping the future of bioprocessing.
Early bird tickets available until 11 September